Future Medicine Launches 'Nanomedicine' Journal
Complete the form below to unlock access to ALL audio articles.
Future Medicine Ltd has announced the launch of its latest title, Nanomedicine (ISSN 1743-5889), which will appear bimonthly from June 2006, and features an acclaimed editorial board of international experts.
"Nanomedicine is emerging as one of the most important sub-disciplines under the nanotechnology umbrella," says Professor Charles R Martin, Director of the Center for Research at the Bio/Nano Interface and Colonel Allen R and Margaret G Crow Professor of Chemistry, University of Florida (FL, USA), and Senior Editor of the journal.
He continued, "The extraordinarily rapid pace at which this field is advancing, clearly justifies the need for a journal devoted specifically to nanomedicine."
Nanomedicine will cover the emerging scientific specialty born from nanotechnology, which has grown up in the fields of engineering, physics, chemistry and biotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond.
Future Medicine claims that, the journal promises to be uniquely medicine-focused, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this information in concise, clear and attractive article formats, including reviews, primary research articles, technology reports, perspectives and editorials.
"Our commitment is to attract the interest of the clinicians that eventually will be the end users of all the nanomedicine knowledge and technology generated," says Kostas Kostarelos, Centre for Drug Delivery Research, University of London (UK) and also Senior Editor of the new journal.
Topics covered will include basic research and theoretical applications, benefits of nanotechnology over traditional techniques, potential medical applications and therapeutic applications of nanotechnology advances, nanomedical tools in gene therapy, drug delivery and commercialization, funding, economics and ethics of nanomedical technology.
The Senior Editors and Future Medicine Ltd aim to make Nanomedicine the main forum in which the challenges and advances in nanotechnology research related to medicine are addressed.
In upcoming years, the field promises much - Nanomedicine will be there to highlight the main advances and therapeutic possibilities for clinicians and researchers alike and will provide an avenue for debate of controversial issues.